Net loss of Surya Pharmaceutical reported to Rs 87.81 crore in the quarter ended June 2012 as against net profit of Rs 24.26 crore during the previous quarter ended June 2011. Sales declined 92.30% to Rs 31.24 crore in the quarter ended June 2012 as against Rs 405.55 crore during the previous quarter ended June 2011.
| Particulars | Quarter Ended |
| | Jun. 2012 | Jun. 2011 | % Var. |
| Sales | 31.24 | 405.55 | -92 |
| OPM % | -72.95 | 17.27 | -522 |
| PBDT | -78.55 | 38.25 | PL |
| PBT | -87.81 | 30.33 | PL |
| NP | -87.81 | 24.26 | PL |